Avsar.

Healthcare · Pharmaceuticals

FDC Ltd (FDC)

₹377.00

Mkt cap
₹6,138 Cr
P/E ratio
18.70
P/B
2.30
Div yield
1.33%
ROE
11.20%
ROCE
15.40%
EPS (TTM)
₹20.16
Book value
₹164
52W range
313–474
Sector
Healthcare

Price history

Previous close

FDC (Fairdeal Corporation) Ltd Limited (found in 1936) is among India’s leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialized formulations, and among the world’s foremost manufacturers and marketers of Oral Rehydration Salts (ORS). . [1]

NSE FDCBSE 531599
Health check
Constructive
ValuationCheap
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−20.40% from high
₹377
₹313+20.47% from low₹474
Current
₹377.00
Prev close
₹377.15
Day
−0.04%
Price performance
1D
+0.23%
1W
+11.60%
1M
+7.97%
3M
−7.23%
6M
+4.06%
1Y
−13.66%
YTD
−10.14%

Financials

Revenue, profit & margin
P/E ratio
18.7×
FDC is 46% below the sector median of 34.4×
FDC18.7×
Sector median34.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales486458462638514464492648473465585668572
Expenses410374406492444417438508439412478525508
Operating Profit768456147704754140345210614364
OPM %16%18%12%23%14%10%11%22%7%11%18%21%11%
Other Income2725202835191636210504818
Interest1111111111211
Depreciation10101011141316151515141516
Profit before tax939865163905153160383614017565
Tax %25%19%29%27%20%28%27%24%26%22%26%24%25%
Net Profit707946119723739121282810313249
EPS in Rs4.294.872.847.314.422.282.387.451.741.746.358.143.01
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +0.95% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast5 Aug '2627 Oct '26◦
Earnings day−4.53%+6.43%
+1 day−4.58%+6.60%
+5 days−7.43%—
+15 days−11.28%—
+30 days−9.04%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Results analysis

Shareholding

as of Sep 2026
69.65%Promoter
Promoters69.65%
FIIs1.57%0.17
DIIs6.59%0.28
Public22.17%0.46
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,777.7034.664,26,5300.90%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹9,780.0087.142,59,6280.31%902+65.50%3,080+27.80%21.97%
Torrent Pharma.₹4,613.4080.831,75,4790.82%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,405.5097.001,29,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,245.5025.521,24,2390.08%990−35.09%8,017+21.96%21.14%
Dr Reddy's Labs₹1,352.0040.301,12,8490.59%913−31.35%8,698−1.48%13.04%
Cipla₹1,378.9035.871,11,3970.94%852−35.05%7,404−2.44%15.49%
FDC₹377.0018.686,1381.33%49+72.93%572+20.95%15.35%
Median: 158 Co.₹426.3834.391,9210.08%14+22.08%175+18.92%15.12%

Filings

Annual reports15
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023Annual Report 2022Annual Report 2021Annual Report 2020Annual Report 2019Annual Report 2018Annual Report 2017Annual Report 2016Annual Report 2015Annual Report 2014Annual Report 2013Annual Report 2012
Concall transcripts16
TranscriptNov 2023PPTNov 2023RECNov 2023PPTFeb 2023TranscriptNov 2022TranscriptNov 2022PPTNov 2022TranscriptAug 2022PPTAug 2022TranscriptMay 2022PPTMay 2022TranscriptFeb 2022TranscriptDec 2021PPTJun 2017PPTNov 2016PPTMay 2016
Announcements5
Public Announcement (Buyback) 29 Oct - FDC approved buyback of 24 lakh shares at ₹500 each, totaling up to ₹120 crore.Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares 29 Oct - FDC approved buyback of up to 24 lakh shares at ₹500 each, aggregate ₹120 crore; record date November 13, 2026.Board Resolution For Buyback Of Fully Paid-Up Equity Shares Of The Company. 28 Oct - Board approved buyback of up to 24 lakh shares at Rs 500 each, totaling Rs 120 crore; record date November 13, 2026.The Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026. 27 OctCorporate Action- Record Date For Buyback. 27 Oct